Alhambra Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$261K Buy
2,067
+209
+11% +$27.5K 0.11% 146
2026
Q1
$259K Sell
1,858
-50
-3% -$7K 0.12% 149
2025
Q4
$234K Buy
1,908
+23
+1% +$2.79K 0.11% 154
2025
Q3
$209K Buy
+1,885
New +$214K 0.1% 167
2024
Q1
Sell
-2,711
Closed -$220K 167
2023
Q4
$220K Sell
2,711
-200
-7% -$15.6K 0.13% 145
2023
Q3
$218K Buy
+2,911
New +$224K 0.14% 135
2023
Q2
Sell
-2,581
Closed -$214K 150
2023
Q1
$214K Sell
2,581
-193
-7% -$16K 0.15% 132
2022
Q4
$238K Buy
+2,774
New +$220K 0.17% 125

Other funds holding GILD

Alhambra Investment Management's GILD Position: Q2 2026 in Review

Alhambra Investment Management increased its Gilead Sciences (GILD) stake by 11% in Q2 2026, buying an estimated $27.5K and bringing the position to 2,067 shares worth $261K. The position accounts for 0.11% of the portfolio, ranked #146.

Alhambra Investment Management first reported a position in GILD in Q4 2022 and has held it in 8 quarters since. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Alhambra Investment Management held 2,067 shares of Gilead Sciences worth $261K as of Q2 2026.
  • Alhambra Investment Management bought 209 Gilead Sciences shares in Q2 2026, an estimated $27.5K.
  • Gilead Sciences made up 0.11% of Alhambra Investment Management's portfolio in Q2 2026, its #146 holding.
  • Alhambra Investment Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 8 quarters since.
  • 837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alhambra Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.